| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Digestive Organs, Department of Cancer Survey, Osaka Medical
Center for Cancer and Cardiovascular Diseases, 1-3-3, Nakamichi, Higashinari,
Osaka, 537-8511, Japan.
2 Department of Diagnostic Radiology, Osaka Medical Center for Cancer and
Cardiovascular Diseases, Osaka, 537-8511, Japan.
OBJECTIVE. The aim of this study was to examine the usefulness of dynamic sonography in the characterization of pancreatic tumors.
MATERIALS AND METHODS. IV contrast-enhanced pancreatic sonography (dynamic sonography) with Levovist was performed in 43 patients with pancreatic mass lesions (32 with pancreatic adenocarcinomas, four with inflammatory pancreatic masses, three with islet cell tumors, two with serous cystadenomas, one with a solid and cystic tumor, and one with metastatic pancreatic cancer). We calculated a contrast index using a time—intensity curve: contrast index equals elevation of intensity in the tumor divided by elevation of intensity in the pancreatic parenchyma. We classified the tumors into three groups according to the contrast index: a slightly enhanced group (contrast index < 0.5), a moderately enhanced group (contrast index = 0.5-1.5), and a well-enhanced group (contrast index > 1.5), and we compared these results with those from dynamic CT.
RESULTS. The contrast indexes of 32 adenocarcinomas, four inflammatory pancreatic masses, three islet cell tumors, two serous cystadenomas, one solid and cystic tumor, and one metastatic tumor were, respectively, 0.12 ± 0.095 (mean ± SD), 0.54 ± 0.420, 1.74 ± 0.555, 1.09 ± 1.380, 1.67, and 2.07. Thirty-five tumors, including all 32 adenocarcinomas, were classified in the slightly enhanced group, three were classified in the moderately enhanced group, and five were classified in the well-enhanced group. In 93% (40/43) of tumors, the grade of enhancement on dynamic sonography was closely correlated with the grade of enhancement on dynamic CT.
CONCLUSION. Dynamic sonography can assist in the characterization of pancreatic tumors.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. D'Onofrio, A. J. Megibow, N. Faccioli, R. Malago, P. Capelli, M. Falconi, and R. P. Mucelli Comparison of Contrast-Enhanced Sonography and MRI in Displaying Anatomic Features of Cystic Pancreatic Masses Am. J. Roentgenol., December 1, 2007; 189(6): 1435 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Wang, J. Tang, L. An, W. Wang, Y. Luo, J. Li, and J. Xu Contrast-Enhanced Ultrasonography for Assessment of Tumor Vascularity in Hepatocellular Carcinoma J. Ultrasound Med., June 1, 2007; 26(6): 757 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Saftoiu, C. Popescu, S. Cazacu, D. Dumitrescu, C. V. Georgescu, M. Popescu, T. Ciurea, and F. Gorunescu Power Doppler endoscopic ultrasonography for the differential diagnosis between pancreatic cancer and pseudotumoral chronic pancreatitis. J. Ultrasound Med., March 1, 2006; 25(3): 363 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takeshima, T. Kumada, H. Toyoda, S. Kiriyama, M. Tanikawa, H. Ichikawa, T. Kawachi, and S. Ogawa Comparison of IV Contrast-Enhanced Sonography and Histopathology of Pancreatic Cancer Am. J. Roentgenol., November 1, 2005; 185(5): 1193 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Kitano, M Kudo, K Maekawa, Y Suetomi, H Sakamoto, N Fukuta, R Nakaoka, and T Kawasaki Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography Gut, June 1, 2004; 53(6): 854 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Numata, Y. Ozawa, N. Kobayashi, T. Kubota, N. Akinori, Y. Nakatani, K. Sugimori, T. Imada, and K. Tanaka Contrast-Enhanced Sonography of Autoimmune Pancreatitis: Comparison With Pathologic Findings J. Ultrasound Med., February 1, 2004; 23(2): 199 - 206. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
